90
|
Bio-Techne corporation
pram1 antibody Pram1 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pram1+antibody/bio-techne+corporation___nb100-821?v=Bio-Techne+corporation Average 90 stars, based on 1 article reviews
pram1 antibody - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
85
|
Santa Cruz Biotechnology
pram 1 Pram 1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pram1+antibody/pmc03789382-283-59-60?v=Santa+Cruz+Biotechnology Average 85 stars, based on 1 article reviews
pram 1 - by Bioz Stars,
2026-06
85/100 stars
|
Buy from Supplier |
N/A
|
Complete remission of acute promyelocytic leukemia can be achieved by treating patients with retinoic acid, and PML-RAR-a (promyelocytic leukemia-retinoic acid receptor alpha fusion protein) plays a major role in mediating retinoic acid effects in leukemia
|
Buy from Supplier |
N/A
|
Complete remission of acute promyelocytic leukemia can be achieved by treating patients with retinoic acid, and PML-RAR-a (promyelocytic leukemia-retinoic acid receptor alpha fusion protein) plays a major role in mediating retinoic acid effects in leukemia
|
Buy from Supplier |
N/A
|
Complete remission of acute promyelocytic leukemia can be achieved by treating patients with retinoic acid, and PML-RAR-a (promyelocytic leukemia-retinoic acid receptor alpha fusion protein) plays a major role in mediating retinoic acid effects in leukemia
|
Buy from Supplier |
N/A
|
Complete remission of acute promyelocytic leukemia can be achieved by treating patients with retinoic acid, and PML-RAR-a (promyelocytic leukemia-retinoic acid receptor alpha fusion protein) plays a major role in mediating retinoic acid effects in leukemia
|
Buy from Supplier |
N/A
|
Complete remission of acute promyelocytic leukemia can be achieved by treating patients with retinoic acid, and PML-RAR-a (promyelocytic leukemia-retinoic acid receptor alpha fusion protein) plays a major role in mediating retinoic acid effects in leukemia
|
Buy from Supplier |
N/A
|
Complete remission of acute promyelocytic leukemia can be achieved by treating patients with retinoic acid, and PML-RAR-a (promyelocytic leukemia-retinoic acid receptor alpha fusion protein) plays a major role in mediating retinoic acid effects in leukemia
|
Buy from Supplier |
N/A
|
The PRAM1 Antibody [Alexa Fluor® 700] from Novus is a PRAM1 antibody to PRAM1. This antibody reacts with Human. The PRAM1 antibody has been validated for the following applications: Immunohistochemistry-Paraffin.
|
Buy from Supplier |
N/A
|
The PRAM1 Antibody [DyLight 755] from Novus is a PRAM1 antibody to PRAM1. This antibody reacts with Human. The PRAM1 antibody has been validated for the following applications: Immunohistochemistry-Paraffin.
|
Buy from Supplier |
N/A
|
The PRAM1 Antibody [Janelia Fluor® 549] from Novus is a PRAM1 antibody to PRAM1. This antibody reacts with Human. The PRAM1 antibody has been validated for the following applications: Immunohistochemistry-Paraffin.
|
Buy from Supplier |
N/A
|
Complete remission of acute promyelocytic leukemia can be achieved by treating patients with retinoic acid, and PML-RAR-a (promyelocytic leukemia-retinoic acid receptor alpha fusion protein) plays a major role in mediating retinoic acid effects in leukemia
|
Buy from Supplier |